Tatva chintan pharma Chem Limited has announced a scheduled virtual investor meeting with Emerge Capital, demonstrating the company's commitment to maintaining transparent investor relations and regulatory compliance.

Meeting Details and Schedule

The company has formally disclosed its upcoming investor engagement through a regulatory filing dated March 14, 2026. The meeting details are structured as follows:

Regulatory Compliance Framework

The disclosure has been made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. This regulation mandates listed companies to inform stock exchanges about material events and information that could impact investor decisions.

The company has specifically clarified that discussions during the interaction will be limited to publicly available information only. No confidential or unpublished price sensitive information (UPSI) will be shared during the meeting, ensuring compliance with insider trading regulations.

Information Accessibility

Tatva Chintan Pharma Chem Limited has committed to making the meeting information available on its official website at www.tatvachintan.com . This approach ensures broader accessibility of information to all stakeholders and maintains transparency standards.

The company has noted that the scheduled meeting is subject to change, providing flexibility while maintaining proper disclosure protocols. The filing was signed by Ishwar Nayi, Company Secretary and Compliance Officer, on March 14, 2026, reflecting the company's adherence to corporate governance practices.

Tatva chintan pharma Chem Limited has disclosed its strategic investment in renewable energy infrastructure through the acquisition of equity shares in AMPIN C&I Power Twenty Six Private Limited. The pharmaceutical company announced this development on 18 February 2026, marking a significant step towards sustainable energy sourcing for its operations.

Investment Structure and Financial Details

The company has entered into multiple agreements to facilitate this green energy acquisition, including a Power Purchase Agreement, Share Purchase and Subscription Agreement, and Option Agreement. The investment involves acquiring 40,00,000 equity shares at Rs 10 per share, representing a total investment of Rs 4,00,00,000.

Renewable Energy Project Specifications

AMPIN C&I Power Twenty Six Private Limited serves as a Special Purpose Vehicle incorporated specifically for establishing renewable power plants in Gujarat. The project encompasses both solar and wind energy generation capabilities designed for captive consumption under the Group Captive Power Scheme.

Strategic Benefits and Business Impact

This acquisition enables Tatva Chintan to source environment-friendly green energy for long-term captive consumption, supporting the company's sustainability objectives. The arrangement is expected to reduce energy costs significantly while ensuring compliance with Indian electricity laws as a captive user. The investment aligns with the company's commitment to increasing renewable power share in its operations.

Target Entity Background

AMPIN C&I Power Twenty Six Private Limited was incorporated on 17 July 2025 as a subsidiary of AMPIN C&I Power Private Limited. The SPV operates in the renewable energy sector, specifically focusing on wind and solar power generation and transmission for captive consumption. As a recently incorporated entity, the company has not yet commenced business operations.

Regulatory and Completion Timeline

The acquisition does not involve any related party transactions, with no promoter or group company interests in the target entity. The completion timeline depends on obtaining necessary regulatory approvals and consents for open access captive consumption of electricity from relevant authorities. No specific governmental or regulatory approvals are required for the share acquisition itself.